Melissa Martinez, PharmD Candidate

home / authors / melissa-martinez-pharmd-candidate

Articles

Acute lymphoblastic leukemia (ALL) cancer cells in the blood flow -- Image credit: LASZLO | stock.adobe.com

Assessing Philadelphia-Like B-Cell ALL in a Largely Hispanic Population

Amir Ali, PharmD, BCOP;Melissa Martinez, PharmD Candidate;Maryam Saheb Kashaf, PharmD Candidate;Zyanya Rizzo, PharmD Candidate
January 17th 2024

Ph-like ALL may be predominantly prevalent in Hispanic and Latino populations.

Read More

Image Credit: Fabrizio - stock.adobe.com

Novel Drug Combinations in Precision Medicine Are an Emerging Landscape for Pharmacists

Amir Ali, PharmD, BCOP;Merry Ann Sta Maria, PharmD Candidate;Melissa Martinez, PharmD Candidate;Jose Tinajero, PharmD, BCOP
October 10th 2023

A single-center experience at a tertiary medical center precision medicine clinic provides insight.

Read More

Latest Updated Articles

AI patient pharmacist provider interactions ASHP summer
Published: June 11th 2024 | Updated: July 27th 2024
Balancing Trust and Technology: The Role of AI in Patient-Pharmacist Interactions
AI pharmacy futures AI disparities skin
Published: June 11th 2024 | Updated: July 27th 2024
Addressing Disparities in AI-Driven Diagnostics: Ethical and Practical Implications
Vice President Kamala Harris -- Image credit: Erin Schaff/Pool/AFP | GETTY | People.com
Published: July 23rd 2024 | Updated: July 27th 2024
VP Kamala Harris’s Policies and Stances on Health Care, Reproductive Rights Take Center Stage
3d illustration of Abstract medical background with Diseased liver - Image credit: Rasi | stock.adobe.com
Published: October 18th 2023 | Updated: July 27th 2024
Pharmacists Can Optimize Treatment for Patients with NASH, Decreasing Economic Burden
Small vial of influenza vaccine.
Published: July 23rd 2024 | Updated: July 27th 2024
Trivalent Influenza Vaccines Are Readied for Fall
Eye Care Pharmacy | Image Credit: I Viewfinder - stock.adobe.com
Published: July 15th 2024 | Updated: July 27th 2024
Biosimilar Ranibizumab Could be More Cost-Effective Than Aflibercept for nAMD